...
首页> 外文期刊>P & T: a peer-reviewed journal for formulary management >Otiprio: An FDA-Approved Ciprofloxacin Suspension Gel for Pediatric Otitis Media With Effusion
【24h】

Otiprio: An FDA-Approved Ciprofloxacin Suspension Gel for Pediatric Otitis Media With Effusion

机译:otiprio:FDA批准的CiProfloxacin悬浮凝胶,用于儿科中耳炎介质具有积液

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: Otitis media (OM), inflammation of the middle ear, is the most common condition for which antibiotics are prescribed for children in the United States, Treatment of acute OM focuses on eradication of Streptococcus pneumoniae, Haemophilus influence, and Moraxella catarrhalis, the bacteria types most frequently associated with these infections. Children may also develop persistent fluid in the middle ear, also known as otitis media with effusion (OME), in the presence of or in the absence of an acute ear infection. Some may continue to suffer from recurrent episodes of acute OM and are often referred to otolaryngologists for consideration of tympanostomy tube (TT) placement. TT placement (TIP) in children with recurrent acute OM or chronic OME is the most common pediatric ambulatory surgery in the United States, with approximately one million surgeries being performed annually.
机译:介绍:中耳炎(OM),中耳炎的炎症,是美国儿童规定抗生素的最常见条件,急性官员的治疗侧重于根除肺炎链球菌,嗜血杆菌的影响和静脉Catarrhalis, 细菌类型最常与这些感染相关。 儿童也可能在中耳中发育持久的液体,也称为具有积液(OME)的中耳炎培养基,在没有急性耳感染的情况下存在。 有些人可能继续患有急性OM的复发发作,并且通常被称为耳鼻喉科医生,以考虑鼓膜术管(TT)放置。 急性急性om或慢性ome儿童的TT放置(尖端)是美国最常见的儿科车身手术,每年进行大约一百万个手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号